Quotation of service vaccine

BCG

TB vaccine

Each tube (10 doses) contains: BCG live, freezing 0.5mg

0.5mg BCG live, freezing

Injection in the skin

Dried powder

Tube

10

Infanrix Hexa

Combining vaccine for 6 diseases: diphtheria, pertussis, tetanus, polio, hib, hepatitis B

N.

After reverting 01 dose (0.5 ml) containing: Eucalyptus detox ≥30 IU; Tetanintic detox ≥40 IU; Bordetella pertussis antigens include 25 mcg pertussis detoxification and 25 mcg and pertacin 8 mcg red blood cells; Antigen surface of hepatitis B virus 10 mcg; Virus polio type 1 inactivation (Mahoney) 40du; Inactive 2-type virus (MEF-1 strain) 8DU; The virus is inactive 3 (afterket) 32 travel; Haemophilus Influenza's polysachari

Intramuscularly

Hib dry and fluid (DTPA-HBV-IPV) to mix the injection mixture

Dose

20

Hexaxim

Combining vaccine for 6 diseases: diphtheria, pertussis, tetanus, polio, hib, hepatitis B

N. Degrees: 0.5 ml/dose.

Each dose of 0.5 ml contains: Diphore detoxification: No less than 20 IU; Tetanintic detoxification: No less than 40 IU; Bordetella pertussis antigen: Detoxifying pertussis (PT): 25 mcg, fiber red blood cells (FHA): 25 mcg; Polio virus (inactivated): Type 1 (Mahoney): 40 units of antigen D, Type 2 (MEF) -1): 8 units of Khkasng Nguyen D, Type 3 (afterket): 32 units of antigen D; Hepatitis B surface antigen: 10 mcg; Polysacchride of Haemophilus Influenzae B (Polyribosylribitol phosphate): 12 mcg plus tetanus protein 22-36 mcg

Intramuscularly

Injection

Syringe

10

Synflorix

Vaccine to prevent pneumococcal pneumonia

N.

One dose (0.5ml) contains 1 mcg polysaccharide of serum types 1 1,2, 5 1,2, 6b1,2, 9v1,2, 141,2, 23f1,2 and 3 mcg of serum types 41,2, 18C1.3, 19f1,4.

Intramuscularly

Injection

Dose

10

Prevenar 13

Polysacharide vaccine plus protein with CRM197

N.D

Type 1 polysacharide pneumococcal bacteria 2.2mcg; Type 3 polysacharide pneumococcal bacteria 2.2mcg; Type 4 polysacharide pneumococcal serum is 2.2mcg; Type 5 polysacharide pneumococcal bacteria 2.2mcg; Type 6A polysacharide pneumococcal bacteria 2.2mcg; Type 6B polysacharide pneumococcal bacteria 2.2mcg; Type 7F polysacharide pneumococcal bacteria 2.2mcg; Type 9V polysacharide pneumococcal bacteria 2.2mcg; Type serum 14 polysacharide pneumococcal bacteria 2.2mcg; Type 18C polysacharide pneumococcal serum is 2.2mcg; Type 19A polysacharide pneumococcal serum is 2.2mcg; Type 19F polysacharide pneumococcal serum is 2.2mcg; Type 23F polysacharide pneumococcal bacteria 2.2mcg; Plus the CRM197 transport protein 32mcg.

Intramuscularly

Injection

Injecting pump (= dose)

10

Rotavin -m1

Rotavirus gastritis vaccine

Rotavirus lives, reduces the type of type Gip [8]

≥2x106 pfu/2ml

Drink

Oral solution

Jar

20

Rotarix

Rotavirus gastritis vaccine

1.5 ml/dose

≥106.0 ccid50 /1.5ml

Drink

Drinking solution/oral solution

Tube

10

Vaxigrip Tetra

Seasonal flu vaccine

0.5 ml/ dose (concentration/ content)

Each dose of 0.5 ml of vaccine (thin, inactive) contains: a/Victoria/4897/2022 (H1N1) PDM09 - Using the same strain (A/Victoria/4897/2022, IVR -238) 15MCG HA; A/Darwin/9/2021 (H3N2) - Use equivalent strains (a/darkwin/9/2021, IVR -228) 15 mcg HA; B/Austria/1359417/2021 - Use equivalent strains (b/michigan/01/2021, wild strain) 15 mcg ha; B/phuket/3073/2013 - Use the same strain (b/phuket/3073/2013, wild strain) 15 mcg ha

Intramuscular/ injection under the skin

Injection

Injecting pump = dose)

20

Influvac Tetra

Seasonal flu vaccine

N.

Each dose of 0.5 ml of vaccine contains: A/Darwin/9/2021 (H3N2)-Like Strain (A/Darwin/9/2021, SAN-010) 15 mcg haemagglutinin, A/Victoria/4897/2022 (H1N1) PDM09-Like Strain (A/Victoria/4897/2022/2022, IVR -238) 15MCG) 15MCG) 15MCG) 15MCG) Aemagglutinin, B/Austria/1359417/2021- Like Strain (B/Michigan/01/2021, BVR-26) 15 McG HAEMAGGLUTININ, B/PHUKET/3073/2013-LIKE Strain (B/Phuket/3073/2013, Wild Type) 15 mcg haemagglutinin.

Intramuscularly/ injected under the skin

Injection

Injecting pump = dose

10

Gcflu Quadrivalent Pre-Filled Syringe Inj

Influenza vaccine

N.

Pure antigen inactivated influenza A H1N1 virus pure antigen inactivation A H3N2 virus with pure antigen inactivation virus B virus B virus pure antigen

Intramuscularly

Injection

Injecting pump = dose

10

VA- Mengo - BC

EXTRACTIVE VACK

VKNMC EXHILITY PROTECTIVE B-50MCG/0.5ml

50mcg/0.5ml 50mcg/0.5ml

Intramuscular injection

Injection

Jar

20

Imojev

Japanese encephalitis vaccine B

N.

Japanese encephalitis virus in SA 14-14-2, recombinant, living, reducing poison 4.0-5.8 log pfu

Inject

Dried powder

Box/dose

10

MMR II

Room coordination vaccine: measles - mumps - rubella

0.5ml/ dose (concentration/ content)

Vials (0.5ml): Measy virus ≥ 1,000 ccID50; Mumps virus ≥ 12,500 ccID50; Rubella virus ≥ 1,000 ccID50

Intramuscularly or subcutaneous

Dried powder

Jar

10

MMR

Room coordination vaccine: measles - mumps - rubella

Concentration/ content: 0.5ml/ dose

Each dose of 0.5 ml reverting vaccine contains: Meeting virus ≥ 1000 ccID50; Mumps virus ≥ 5000 ccID50; Rubella virus ≥ 1000 ccID50;

Injection subcutaneously

Dried powder

Jar

20

Varilrix

Chickenpox vaccine

Concentration/ content: ≥ 103.3 pfu

Chickenpox virus reduces poison (strain OKA) ≥ 103.3 pfu

Subcutaneous

East dried powder and injection solution

Box/ dose

10

Varivax

Chickenpox vaccine

Concentration/ content: ≥ 1350 pfu/ vial

OKA/Merk Varicella Virus, Live, Attenations ≥ 1350 PFU/Vial

Inject

East dried powder with solvent

Box/ dose

10

Heeberbiovac HB

Inflammation vaccine B recombinant

Concentration/ content: 10mcg/ 0.5ml

HBsAg surface protein (purity ≥ 95%)

Intramuscularly

Injection

Jar

10

Heeberbiovac 1 ml

Inflammation vaccine B recombinant

Concentration/ content: 20mcg/ 1ml

HBsAg surface protein (purity ≥ 95%)

Intramuscular injection

Injection mixture

Jar

10

Gardasil 9

Cancellate Cervical Cancer Vaccination

Concentration/ content: 0.5 ml

Each dose of 0.5ml contains 30mcg protein L1 HPV type 6; 40 mcg protein l1 hpv type 11; 60 mcg protein l1 hpv type 16; 40 mcg protein l1 hpv type 18; 20 mcg protein L1 HPV for each typs 31, 33, 45.52 and 58

Intramuscularly

Injection

box/ dose/ injection pump

10

Qdenga

Dengue vaccine is caused by the Dengue virus

Den-1, Den-2, Den-3, Den-4

Den-1 ≥ 3.3 log10 pfu/dose; Den-2 ≥ 2.7 log10 pfu/dose; Den-3 ≥ 4.0 log10 pfu/dose; Den-4 ≥ 4.5 log10 pfu/dose

Subcutaneous

Powder mixing solution

Jar

10

Verorab

Room vaccine

Concentration/content: ≥ 2.5 IU/0.5 ml/dose

Each dose of 0.5 ml vaccine contains: Inactive rabies virus (Wistar PM/Wi 38 1503 - 3M) ≥ 2.5 IU

Intramuscular/ injection in the skin

East dried powder vaccine and reconstituted solvent

Jar

10

Abhayrab

Room vaccine

Concentration/ content: ≥ 2.5 IU/ 0.5 ml

Inactive rabies virus (strain L. Paster 2061/Vero is propagated on Vero cells)

Intramuscular/ injection in the skin

East dried powder injected

Jar

10

TT

Adsorbine tetanus vaccine

Crystal tetanus detoxification

≥ 40 IU/0.5 ml

Intramuscular injection

Injection

Tube

40

SAT

Refined tetanus serum serum

Globulin resistant tetanus toxin

1500 IU

Intramuscularly

Injection solution

Tube

40

Havax

Hepatitis A vaccine pure, inactivated

Concentration/ content: 0.5ml/ dose

Protein includes pure hepatitis A virus

Intramuscularly

Injection mixture

Jar

10